Thyrocare Tech Peer Comparison
NSE: THYROCARE | BSE: 539871
₹456.30
As on 30-Oct-2026IST
Market cap
₹7,274 Cr
Revenue (TTM)
₹930 Cr
P/E Ratio
50.4
P/B Ratio
13.1
Div. Yield
3.1 %
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
7,274 | 8,402 | 4,626 | 2,797 | 2,167 |
Revenue (₹ Cr) |
930 | 1,621 | 1,150 | 1,555 | 429 |
Net Profit (₹ Cr) |
140.93 | 186.64 | 115.06 | 192.13 | 80.36 |
Net Margin (%) |
14.88 | 11.24 | 9.76 | 12.11 | 18.25 |
RoE (%) |
30.04 | 11.98 | 12.16 | 24.71 | 17.20 |
Price to Earnings |
50.44 | 45.07 | 40.32 | 14.56 | 26.97 |
Price-To-Book |
13.14 | 5.15 | 5.16 | 3.43 | 4.41 |
Income Statement (₹ Cr)
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Operating Revenue
|
930.31 | 1,620.68 | 1,149.94 | 1,555.42 | 428.94 |
|
Total Income
|
947.38 | 1,660.09 | 1,178.64 | 1,586.87 | 440.23 |
|
Total Expenditure
|
630.83 | 1,261.98 | 942.52 | 1,275.71 | 280.15 |
|
EBITDA
|
299.48 | 358.71 | 207.42 | 279.71 | 148.79 |
|
Depreciation
|
61.67 | 99.88 | 52.43 | 46.61 | 49.09 |
|
EBIT
|
237.81 | 258.83 | 155.00 | 233.10 | 99.70 |
|
Interest
|
4.35 | 43.25 | 27.00 | 6.26 | 1.10 |
|
Other Income
|
17.07 | 39.41 | 28.70 | 31.45 | 11.30 |
|
Exceptional Items
|
-51.14 | -4.89 | -3.07 | 0.00 | -1.62 |
|
Profit before Tax
|
199.39 | 250.10 | 153.62 | 258.29 | 108.28 |
|
Provision for Tax
|
58.46 | 63.47 | 38.57 | 66.16 | 27.93 |
|
Profit after Tax
|
140.93 | 186.64 | 115.06 | 192.13 | 80.36 |
Liabilities (₹ Cr)
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
553.43 | 1,630.32 | 989.50 | 814.43 | 491.36 |
|
Minority Interest
|
0.90 | -0.21 | -0.35 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
61.74 | 683.33 | 339.44 | 80.75 | 36.82 |
|
Current Liabilities
|
110.97 | 246.27 | 263.00 | 223.26 | 65.08 |
|
Total Liabilities
|
804.51 | 2,363.30 | 1,507.57 | 991.36 | 562.23 |
Assets (₹ Cr)
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
268.70 | 1,548.59 | 890.85 | 359.00 | 326.86 |
|
Current Assets
|
376.50 | 614.70 | 477.48 | 513.39 | 254.00 |
|
Total Assets
|
804.51 | 2,363.30 | 1,507.57 | 991.36 | 562.23 |
|
Total Debt*
|
0.00 | 508.53 | 226.86 | 0.00 | 3.33 |
|
Net Current Assets
|
265.53 | 368.43 | 214.48 | 290.13 | 188.92 |
|
Contingent Liabilities
|
1.86 | 4.93 | 205.54 | 106.61 | 1.95 |
Cashflow (₹ Cr)
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
213.24 | 267.71 | 131.95 | 167.44 | 147.14 |
|
Cash Flow from Investing Activities
|
-23.01 | -441.93 | -90.03 | -177.61 | -129.67 |
|
Cash from Financing Activities
|
-169.59 | 136.47 | -50.10 | -46.38 | -10.35 |
|
Net Cash Inflow / Outflow
|
20.64 | -37.76 | -8.18 | -56.55 | 7.12 |
Ratios
Profitability Ratios
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
ROCE (%)
|
38.30 | 15.70 | 15.83 | 37.70 | 24.81 |
|
ROE (%)
|
30.04 | 11.98 | 12.16 | 24.71 | 17.20 |
|
ROA (%)
|
20.06 | 8.14 | 7.61 | 18.54 | 14.46 |
|
EBIT Margin (%)
|
25.56 | 15.97 | 13.48 | 14.99 | 23.24 |
|
Net Margin (%)
|
14.88 | 11.24 | 9.76 | 12.11 | 18.25 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
21.99 | 14.45 | 14.77 | 10.72 | 11.77 |
|
EBIT Growth (%)
|
36.05 | 2.55 | 29.91 | 8.51 | 5.04 |
|
Net Profit Growth (%)
|
11.07 | -6.18 | 21.47 | 9.95 | 7.64 |
|
EPS Growth (%)
|
-55.41 | -41.99 | 7.69 | 9.95 | -26.49 |
|
Book Value Growth (%)
|
6.70 | 13.85 | 13.11 | 24.08 | 20.79 |
Valuation Ratios
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Price / Earnings
|
42.53 | 14.59 | 39.53 | 14.56 | 26.55 |
|
Price / Book Value
|
13.14 | 5.15 | 5.16 | 3.43 | 4.41 |
|
Dividend Yield (%)
|
3.06 | 0.08 | 0.15 | 1.31 | 0.41 |
|
EV/EBITDA
|
23.55 | 23.33 | 22.40 | 9.06 | 14.14 |
|
Market Cap (₹ Cr)
|
5,567.00 | 8,344.51 | 3,249.24 | 3,406.96 | 1,701.05 |
Solvency Ratios
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.35 | 0.20 | 0.00 | 0.02 |
|
Short term debt to equity ratio
|
-- | -- | -- | -- | -- |
|
Current Ratio
|
3.39 | 2.50 | 1.82 | 2.30 | 3.90 |
|
Quick Ratio
|
2.95 | 2.35 | 1.75 | 2.26 | 3.45 |
|
Interest Coverage
|
46.84 | 6.78 | 6.69 | 42.26 | 99.44 |
Operating Efficiency Ratios
| Thyrocare Tech | Jupiter Life Line | Artemis Medicare | Indraprastha Med | Vimta Labs | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
9.60 | 7.30 | 13.79 | 8.46 | 27.80 |
|
Asset Turnover
|
1.32 | 0.71 | 0.76 | 1.50 | 0.77 |
|
Receivable days
|
32.33 | 14.45 | 37.29 | 23.10 | 94.97 |
|
Inventory Days
|
20.91 | 7.88 | 3.95 | 1.83 | 24.65 |
|
Payable days
|
117.68 | 104.59 | 143.48 | -- | -- |
|
Cash Conversion Cycle
|
-64.44 | -82.26 | -102.24 | -- | -- |